Muthusamy Shanmugam - 26 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship: HEAD OF R&D, COO-NOVITIUM OPS, Director
Issuer ticker: ANIP
Reported as of: 26 Feb 2026
Net transaction value: +$857,599
SEC form: 4
Accepted by SEC: 02 Mar 2026, 17:59:46 UTC
Prior SEC filing: 13 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook

Key filing fact

Muthusamy Shanmugam filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 02 Mar 2026.

Key facts

This page summarizes Muthusamy Shanmugam's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Mar 2026, 17:59.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: +$857,599.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001870913 Primary reporting owner

Shanmugam Muthusamy

Relationship: HEAD OF R&D, COO-NOVITIUM OPS, Director
Address: C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE
Signature: /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Signature date: 02 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Award

Transaction value: $857,599
Shares: +11,116
Change %: +12%
Price: $77.15
Shares after: 101,056
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

ANIP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 431,920
Date: 26 Feb 2026
Ownership: Held by Esjay LLC
Footnotes: F2

ANIP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,000
Date: 26 Feb 2026
Ownership: Held by SS Pharma LLC
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.

Footnote F2

The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Footnote F3

The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.